USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing

Area of Science:

• Veterinary immunology
• Vaccine development
• Bacteriology

Background:

• Historically, leptospiral vaccine potency was assessed using animal vaccination-challenge models mandated by the United States Department of Agriculture (USDA).
• Specific hamster vaccination-challenge assays were codified for various Leptospira serogroups starting in the 1970s.
• These assays involved vaccinating hamsters, challenging them with virulent Leptospira, and observing mortality rates, with 80% survival required for vaccine efficacy.

Observation:

• The established hamster vaccination-challenge assays are resource-intensive, incurring significant monetary costs and raising animal welfare concerns.
• The Center for Veterinary Biologics (CVB) recognized the limitations of these traditional methods.
• Alternative potency testing methods are being explored to improve efficiency and ethical considerations.

Findings:

• The high cost and animal welfare implications of traditional assays prompted the development of Enzyme-Linked Immunosorbent Assays (ELISA) as alternatives.
• ELISA offers a potentially more cost-effective and humane approach to batch-release potency testing.
• Potency testing for serogroups without codified requirements, like Leptospira hardjo-bovis, is managed individually.

Implications:

• The adoption of ELISA alternatives could streamline vaccine release processes and reduce the ethical burden associated with animal testing.
• Developing standardized ELISA methods will be crucial for regulatory acceptance and widespread implementation.
• This shift represents a move towards more modern, efficient, and animal-sparing techniques in veterinary biologics quality control.